Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients

Mian, S., Ugurel, S., Parkinson, E., Schlenzka, I., Dryden, I., Lancashire, L., Ball, G. ORCID: 0000-0001-5828-7129, Creaser, C., Rees, R. ORCID: 0000-0002-4574-4746 and Schadendorf, D., 2005. Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. Journal of Clinical Oncology, 23 (22), pp. 5088-5093. ISSN 0732-183X

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Journal of Clinical Oncology
Creators:	Mian, S., Ugurel, S., Parkinson, E., Schlenzka, I., Dryden, I., Lancashire, L., Ball, G., Creaser, C., Rees, R. and Schadendorf, D.
Publisher:	American Society of Clinical Oncology
Place of Publication:	Alexandria, VA
Date:	2005
Volume:	23
Number:	22
ISSN:	0732-183X
Identifiers:	Number Type 10.1200/JCO.2005.03.164 DOI
Divisions:	Schools > School of Science and Technology
Record created by:	EPrints Services
Date Added:	09 Oct 2015 10:58
Last Modified:	11 Oct 2021 12:45
URI:	https://irep.ntu.ac.uk/id/eprint/20830

Actions (login required)

Edit View

Views

Downloads